Literature DB >> 3936702

Resistance of 1-deamino-[8-D-arginine]-vasopressin to in vitro degradation as compared with arginine vasopressin.

K Matsui, T Kimura, K Ota, K Iitake, M Shoji, M Inoue, K Yoshinaga.   

Abstract

In order to elucidate the mechanism(s) responsible for the prolonged antidiuretic activity of 1-deamino-[8-D-arginine]-vasopressin (dDAVP), antidiuretic activities of dDAVP and arginine vasopressin (AVP) were determined in the rat following either oral administration or incubation with AVP-degrading enzymes and reagents. Oral administration of dDAVP to conscious water-loaded rats resulted in significant antidiuresis while AVP resulted in slight and transient antidiuresis. In the ethanol anesthetized water-loaded rats, antidiuretic activities of 136pg of AVP and 50pg of dDAVP, which were found to be equipotent, were compared after incubation with digestive enzymes (pepsin, trypsin, alpha-chymotrypsin), late pregnancy plasma, or sodium thioglycollate. The antidiuretic activity of AVP was completely destroyed by 30-min incubation with trypsin, alpha-chymotrypsin, or late pregnancy plasma and almost all AVP was inactivated by 0.2 M sodium thioglycollate. On the other hand, the antidiuretic activity of dDAVP was not destroyed by trypsin or pregnancy plasma but was partly destroyed by alpha-chymotrypsin and sodium thioglycollate. Neither the antidiuretic activity of AVP nor that of dDAVP was affected by pepsin. Thus, the antidiuresis observed after oral administration of dDAVP might be brought about by the resistance to digestive enzymes. Furthermore, the resistance of dDAVP to digestive enzymes, late pregnancy plasma and sodium thioglycollate might be responsible for the prolonged antidiuretic action of dDAVP in vivo.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936702     DOI: 10.1507/endocrj1954.32.547

Source DB:  PubMed          Journal:  Endocrinol Jpn        ISSN: 0013-7219


  4 in total

1.  Enhanced intestinal absorption of oxytocin peptide analogues in the absence of pancreatic juice in pigs.

Authors:  D P Lundin; S Lundin; H Olsson; B W Karlsson; B R Weström; S G Pierzynowski
Journal:  Pharm Res       Date:  1995-10       Impact factor: 4.200

2.  Prodrugs of peptides. 18. Synthesis and evaluation of various esters of desmopressin (dDAVP).

Authors:  A H Kahns; A Buur; H Bundgaard
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

3.  Solid lipid particles for oral delivery of peptide and protein drugs III - the effect of fed state conditions on the in vitro release and degradation of desmopressin.

Authors:  Philip C Christophersen; Dimple Vaghela; Anette Müllertz; Mingshi Yang; Hanne M Nielsen; Huiling Mu
Journal:  AAPS J       Date:  2014-05-30       Impact factor: 4.009

4.  Solid lipid particles for oral delivery of peptide and protein drugs II--the digestion of trilaurin protects desmopressin from proteolytic degradation.

Authors:  Philip Carsten Christophersen; Long Zhang; Anette Müllertz; Hanne Mørck Nielsen; Mingshi Yang; Huiling Mu
Journal:  Pharm Res       Date:  2014-03-13       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.